Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Enfermedad de Alzheimer y Demencias

24432 ARTÍCULOS , VIENDO DEL 23911 AL 23925

Objective Criteria for Subtle Cognitive Decline in Aging and Preclinical Alzheimer Disease: A Systematic Review

Thomas KR, Edmonds EC.

Neurology. 2025 May 13;104(9):e213536. doi: 10.1212/WNL.0000000000213536. Epub 2025 Apr 8.

Mind Your Mouth: Impact of Oral Bacteria on Alzheimer's Disease

Mohammed AI, Mohammed AI, Reynolds E.

J Oral Pathol Med. 2026 Jan;55(1):1-6. doi: 10.1111/jop.70111. Epub 2025 Dec 23.

Natural Products in Alzheimer's Disease: A Systematic Review of Clinical Trials and Underlying Molecular Mechanisms

Bayo Jimenez MT, Rivas-García L, Sánchez-González C, Grosso G, Lipari V, Vera-Ramírez L, Battino M, Giampieri F, Quiles JL, Forbes-Hernández TY.

Int J Mol Sci. 2025 Oct 31;26(21):10631. doi: 10.3390/ijms262110631.

Safety and Tolerability of Brexpiprazole in Participants with Agitation Associated with Dementia due to Alzheimer's Disease: Pooled Analysis of Three Randomized Trials and an Extension Trial

Shah A, Estilo A, Sheridan PL, Kalu U, Chen D, Chang D, Slomkowski M, Lee D, Hefting N, Hobart M, Behl S, Such P, Brubaker M, Grossberg GT.

CNS Drugs. 2025 Oct;39(10):1011-1023. doi: 10.1007/s40263-025-01200-9. Epub 2025 Jul 19.

Repurposing glucagon-like peptide-1 receptor agonists for the treatment of neurodegenerative disorders

Sabbagh MN, Cummings JL, Ballard C, van der Flier WM, Heneka MT, Holst JJ, Knudsen LB, Salloway S, Tansey MG, Drucker DJ.

Nat Aging. 2026 Jan;6(1):56-67. doi: 10.1038/s43587-025-01029-3. Epub 2025 Dec 19.

Association Between Choroid Plexus Morphological Alterations, Alzheimer Pathologies, and Cognitive Impairment: A Longitudinal Study

Lin M, Zeng Q, Zhong S, Nie S, Zhang R, Hong H, Liu L, Wang S, Li K, Luo X, Chen Y, Huang P; Alzheimer's Disease Neuroimaging Initiative (ADNI).

Neurology. 2025 Dec 23;105(12):e213953. doi: 10.1212/WNL.0000000000213953. Epub 2025 Nov 24.

Oral PRI-002 treatment in patients with MCI or mild AD: a randomized, double-blind phase 1b trial

Kutzsche J, Cosma NC, Kauselmann G, Fenski F, Bieniek C, Bujnicki T, Pils M, Bannach O, Willbold D, Peters O.

Nat Commun. 2025 May 6;16(1):4180. doi: 10.1038/s41467-025-59295-z.

Intervention Effects of the Holistic Physio-Cognitive Rehabilitation for Alzheimer Disease and Mild Cognitive Impairment

Osawa A, Maeshima S, Kamiya M, Ueda I, Itoh N, Kondo I, Arai H.

Ann Geriatr Med Res. 2025 Jun;29(2):207-212. doi: 10.4235/agmr.24.0158. Epub 2025 Feb 25.

Periventricular diffusivity reflects APOE ε4-modulated amyloid accumulation and cognitive impairment in the Alzheimer's disease continuum

Chen CL, Son SJ, Schweitzer N, Jin H, Li J, Wang L, Yang S, Hong CH, Roh HW, Park B, Choi JW, An YS, Seo SW, Cho YH, Hong S, Nam YJ, Minhas DS, Laymon CM, Stetten GD, Tudorascu DL, Aizenstein HJ, Wu M; Mayo Clinic Study of Aging.

Alzheimers Dement. 2025 Sep;21(9):e70659. doi: 10.1002/alz.70659.

Effects of intermittent theta-burst stimulation on cognition and glymphatic system activity in mild cognitive impairment and very mild Alzheimer's disease: a randomized controlled trial

Yang CC, Huang KY, Hsu JL, Hu CJ, Lu YH, Kuan YC.

J Neuroeng Rehabil. 2025 Sep 26;22(1):195. doi: 10.1186/s12984-025-01738-1.

Inhibition of FAM19A5 reverses synaptic loss and cognitive decline in mouse models of Alzheimer's disease

Kim HB, Yoo S, Kwak H, Ma SX, Kim R, Lee M, Ha N, Pyo S, Kwon SG, Cho EH, Lee SM, Jang J, Kim WK, Park HC, Baek M, Park Y, Park JY, Park JW, Hwang SW, Hwang JI, Seong JY.

Alzheimers Res Ther. 2025 Jul 21;17(1):168. doi: 10.1186/s13195-025-01813-8.

Investigation of patterns and associations of neuroinflammation in cognitive impairment

Gan R, Xie H, Zhao Z, Wu X, Wang R, Wu B, Chen Q, Jia Z.

Cereb Cortex. 2025 Feb 5;35(2):bhaf013. doi: 10.1093/cercor/bhaf013.

Multimodal prognostic modeling of individual cognitive trajectories to enhance trial efficiency in preclinical Alzheimer's disease

Devanarayan V, Donohue MC, Sperling RA, Johnson KA, Ye Y, Charil A, Doherty T, Tian L, Raman R, Aisen PS, Kramer LD, Irizarry MC, Dhadda S.

Alzheimers Dement. 2025 Sep;21(9):e70702. doi: 10.1002/alz.70702.

Computerized cognitive training enhances cognitive function in Alzheimer's disease by downregulating Ruminococcus-TMAO pathway

Zhang W, Song J, Zhong F, Yu W, Qin Z, Yang Z, Liu J, Wang X, Chen L, Lü W, Xing D, Liu J, Huang C, Wu J, Liu X, Yu W, Lü Y.

J Transl Med. 2025 Oct 24;23(1):1173. doi: 10.1186/s12967-025-07209-4.

Amyloid PET and clinical management in a diverse, cognitively impaired population: The New IDEAS Study

Windon CC, Gatsonis C, Carrillo MC, Romanoff J, Hanna L, Glavin E, Gareen I, Gutman R, Hillner BE, March A, O'Bryant S, Rissman RA, Siegel BA, Smith K, Whitmer RA, Weber CJ, Wilkins CH, Dilworth-Anderson P, Rabinovici GD.

Alzheimers Dement. 2025 Jul;21(7):e70504. doi: 10.1002/alz.70504.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias